Metabasis Therapeutics (MBRX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Metabasis Therapeutics (MBRX)

An SI Board Since April 2004

Posts	SubjectMarks	Bans	Symbol
66	9	0	MBRX

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
66	Sold to Ligand Pharmaceuticals for only $3.2M	idos	-	10/27/2009
65	Two good results leading to milestone reimbursements and pre-clinical trial set	mlkr	-	6/29/2009
64	Positive results from MB07803 in poorly controlled T2DM will be presented in Jun	pgo-neil	-	5/6/2009
63	"Promising" results from Ph 1b of 7811 in dyslipidermia. Talk of Ph2	pgo-neil	-	6/19/2008
62	>>Metabasis Presents Preclinical Results for MB07803, Its Product Candidat	tuck	-	6/10/2008
61	I wonder if the C&E News article to be published will go into the comparativ	Biotech Jim	-	4/7/2008
60	Metabasis Therapeutics Presents the Discovery of Its Second-Generation FBPase In	LJM	-	4/7/2008
59	Metabasis Announces Preliminary Safety and Efficacy Results from an Ongoing Phas	LJM	-	1/4/2008
58	>>Metabasis Announces European Commission Grants Orphan Medicinal Product	tuck	-	10/2/2007
57	A couple of semi-coherent things that I remember about MBRX. The CS-917 product	kenhott	-	7/18/2007
56	Too cynical? They're throwing out low baseline levels as an excuse, but to	tuck	-	7/17/2007
55	I think you're being too cynical. They may as well see what 7803 shows and i	rkrw	-	7/17/2007
54	Don’t overlook the HCV drug-discovery collaboration with IDIX. (I’m joking.)	DewDiligence_on_SI	-	7/17/2007
53	So . . . assuming that 2nd generation compound 7803 is also a write-off,	tuck	-	7/17/2007
52	Maybe this is why Daichii was in no rush :-) <<<Metabasis Therapeuti	rkrw	-	7/17/2007
51	<<Don't they talk to their partner/competitor?>>> I get the	rkrw	-	7/13/2007
50	We can hope for EASD in mid-September, I guess. Then the World Diabetes confab	tuck	-	7/13/2007
49	Data is very binary, a lot of people waiting for this. I think mbrx was hoping i	rkrw	-	7/13/2007
48	I imagine the recent weakness in the stock is due the missing of this milestone,	tuck	-	7/13/2007
47	>>Metabasis Therapeutics Announces Initiation of a Clinical Trial for MB07	tuck	-	6/24/2007
46	>>Metabasis Therapeutics Presents Results of Preclinical Studies for MB078	tuck	-	6/6/2007
45	If I were an idix shareholder, I'd be pleased with $200M for 2010 as it woul	rkrw	-	5/4/2007
44	Treatment of chronic HBV is a rapidly evolving arena. I see no reason why $500M	DewDiligence_on_SI	-	5/4/2007
43	Dew correct I was joking. Obviously $500M for 2010 isn't going to happen.	rkrw	-	5/4/2007
42	I’ve been watching Clevudine closely. It is IMO much more of a threat to Tyzeka	DewDiligence_on_SI	-	5/4/2007

Go to reply# or date (mm/dd/yy):